Southwest Private Capital Inc. 13D/13G Filings for BriaCell Therapeutics Corp. (BCTX)

Southwest Private Capital Inc. 13D and 13G filings for BriaCell Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-04-25
4:05 pm
Purchase
2022-04-14 13G BriaCell Therapeutics Corp.
BCTX
Southwest Private Capital Inc. 52,134
5.100%
52,134increase
(New Position)
Filing